Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Cash & Equivalents: 2009-2024

Historic Cash & Equivalents for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to $81.6 million.

  • Cross Country Healthcare's Cash & Equivalents rose 5484.29% to $99.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $99.1 million, marking a year-over-year increase of 5484.29%. This contributed to the annual value of $81.6 million for FY2024, which is 37755.35% up from last year.
  • Per Cross Country Healthcare's latest filing, its Cash & Equivalents stood at $81.6 million for FY2024, which was up 37755.35% from $17.1 million recorded in FY2023.
  • Cross Country Healthcare's Cash & Equivalents' 5-year high stood at $81.6 million during FY2024, with a 5-year trough of $1.0 million in FY2021.
  • In the last 5 years, Cross Country Healthcare's Cash & Equivalents had a median value of $3.6 million in 2022 and averaged $21.0 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 3525.0% in 2021, then surged by 37755.35% in 2024.
  • Over the past 5 years, Cross Country Healthcare's Cash & Equivalents (Annual) stood at $1.6 million in 2020, then tumbled by 35.25% to $1.0 million in 2021, then surged by 247.88% to $3.6 million in 2022, then soared by 374.31% to $17.1 million in 2023, then skyrocketed by 377.55% to $81.6 million in 2024.
  • Its Cash & Equivalents was $81.6 million in FY2024, compared to $17.1 million in FY2023 and $3.6 million in FY2022.